Inari Medical stock soars to 52-week high of $79.7
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of NARI, DFS, LBRDA, CCRN to Act Now
Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is ...
Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025?
We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Inari Medical, Inc. (NARI)
January 21, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Inari Medical, Inc. ("Inari Medical") (NASDAQ: NARI) for ...
UBS initiates Penumbra shares with Buy rating, projects 14% revenue CAGR through 2029
UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.
Fabbaloo6d
The MedTech Merger Shaping the Future: Stryker Acquires Inari Medical for $4.9 Billion
Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...